Physician
Blood and Cancer Therapeutics a Medical Corporation
Blood and Cancer Therapeutics a Medical Corporation was paid $4.19M by Medicaid between Aug 2021 and Nov 2024, across 28 billing codes. Its largest line is J9271, Injection, pembrolizumab, 1 mg — 34% of everything it billed.
33Billing provider infoBLOOD AND CANCER THERAPEUTICS A MEDICAL CORPORATION
BAKERSFIELD, CA 93306
BAKERSFIELD, CA 93306
33aNPI1679184535assigned 08/13/2020
33bProvider typeHematology & Oncology Physician
28Total paid$4.19M
24GClaims41,771
24DCodes billed28
24AFirst – last monthAug 2021 – Nov 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in California
Rank by total paid#6 of 180
Median peer was paid$26K
This provider vs. median163×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 1,142 | $51K | |
| 2022 | 4,690 | $146K | |
| 2023 | 14,176 | $1.13M | |
| 2024incomplete | 21,763 | $2.86M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 34% | 246 | 183 | $1.41M |
| J9299 | Injection, nivolumab, 1 mg | 18% | 167 | 94 | $739K |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 11% | 491 | 235 | $472K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 9.1% | 4,582 | 2,209 | $383K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 5.1% | 3,806 | 1,576 | $212K |
| Q5126 | Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg | 4.8% | 134 | 69 | $203K |
| J9312 | Injection, rituximab, 10 mg | 4.6% | 62 | 24 | $193K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.3% | 929 | 876 | $95K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.2% | 8,523 | 3,221 | $91K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1.7% | 91 | 50 | $72K |
| 96367 | 1.4% | 2,415 | 1,016 | $57K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.2% | 1,003 | 967 | $52K |
16 more codes
| 96415 | 1.1% | 1,401 | $47K | |
| 96417 | 1.0% | 1,683 | $44K | |
| 99205 | Prolong outpt/office vis | <1% | 271 | $35K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 615 | $30K |
| 96368 | <1% | 1,924 | $24K | |
| J1750 | Injection, iron dextran, 50 mg | <1% | 299 | $7K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 6,782 | $6K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 53 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 461 | $5K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 3,613 | $4K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 52 | $3K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 911 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 868 | $632.21 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 228 | $152.78 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 24 | $122.37 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 137 | $74.83 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNGUYEN, VINH-LINH (PRESIDENT/OWNER)
| Provider | Location | Paid |
|---|---|---|
| Bakersfield Hematology Oncology, INC. | Bakersfield, CA | $159K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.